Receiving a diagnosis of peritoneal involvement is often a moment of great vulnerability. However, the International Patient Manifesto on Peritoneal Surface Malignancies (PSOGI 2025 – Barcelona) marks a turning point in modern oncology. At Viamed, through our specialized unit IVOQA, we adhere to this manifesto to ensure that every patient receives the expert and compassionate care they deserve
What are peritoneal malignancies and why this manifesto?
Peritoneal malignancies are tumors that originate in or spread to the peritoneum, the membrane that protects the abdominal organs. As these are complex and often rare pathologies (such as peritoneal pseudomyxoma or mesothelioma), the PSOGI 2025 Manifesto was created to give patients a voice and establish global standards of care that prevent isolation and lack of information.
The Pillars of the PSOGI 2025 Manifesto
This document serves as both an ethical and medical roadmap. At IVOQA, we align our clinical practice with its primary areas of focus:
- Global Awareness: Bringing these diseases out of anonymity to prevent symptoms from being mistaken for common digestive issues.
- Early and Accurate Diagnosis: Time is vital. The manifesto demands standardized diagnostic pathways and access to expert second opinions.
- Access to Centers of Excellence: Ensuring patients are treated in units with proven experience and multidisciplinary teams.
- Equity in Innovation: Universal access to techniques such as cytoreductive surgery and intraperitoneal chemotherapy.
- Research and Quality of Life: It is not just about treating the disease, but also about caring for nutrition, emotional health, and the well-being of the patient and their family.
IVOQA: A Reference Center in Peritoneal Oncology
At IVOQA, Viamed’s specialized institute for complex oncological pathology, we understand that complying with the PSOGI 2025 Manifesto means offering the highest technical excellence.
How do we turn the manifesto into reality at IVOQA?
- Advanced Oncological Surgery: We have surgeons specialized in radical tumor removal (cytoreduction), the treatment with the greatest impact on survival.
- Cutting-Edge Technology (HIPEC/PIPAC): We apply chemotherapy treatments directly into the abdominal cavity to target tumor cells with maximum precision and minimal systemic side effects.
- Multidisciplinary Tumor Board: Every case is analyzed jointly by surgeons, oncologists, and radiologists to provide a personalized plan, as required by international consensus.
The PSOGI 2025 Manifesto is a commitment to patient dignity. At IVOQA and Viamed, we are proud to be part of this change, offering not only state-of-the-art technology but also the human support that makes a difference.
Are you looking for an expert evaluation of your case? Book your Online Appointment with IVOQA.
